Cognitive Support
Cognitive Support Discussion Protocol
Educational protocol for neuroprotective and cognitive peptide research
• This protocol is provided for educational and informational purposes only. It does not constitute medical advice, a diagnosis, a treatment plan, or a prescription.
• All dose ranges, frequencies, durations, and compound selections must be determined by a licensed healthcare professional based on your individual medical history, lab results, and clinical assessment.
• Lab monitoring may be required depending on the compound(s), individual health status, and duration of use. Discuss appropriate monitoring protocols with your clinician.
• Do not use any peptide compound if you are pregnant, breastfeeding, a minor, or have uncontrolled medical conditions without explicit direction from your physician.
High Risk — Specialist Supervision Required
Significant safety considerations; not suitable for unsupervised use
Overview
This protocol covers research discussion points for compounds being studied in the context of neuroprotection, cognitive enhancement, and mental performance support. Given the experimental nature of many compounds in this category, this protocol has a HIGH RISK designation and requires thorough clinician review.
Mechanism Summary
Cognitive-support compounds in research may interact with BDNF (Brain-Derived Neurotrophic Factor), HGF (Hepatocyte Growth Factor), dopaminergic/serotonergic systems, or ACTH-like pathways. Research contexts include neuroplasticity, anxiety modulation, and neuroprotection.
Intended Goal
Prepare for a clinician discussion on cognitive and neuroprotective compounds
Semax
CalculateResearch category: Neuropeptide / cognitive / BDNF modulation
Synthetic peptide studied for cognitive and neuroprotective properties. Catalog reference only.
Selank
CalculateResearch category: Anxiolytic-like neuropeptide / cognitive
Studied for anxiety-modulating and cognitive-enhancement properties. Catalog reference only.
Dihexa
CalculateResearch category: Cognitive / HGF modulator (experimental)
Experimental compound explored in Alzheimer's research context. Very limited human data.
Who may be a candidate
- ✓Adults under medical care for cognitive concerns
- ✓Individuals working with neurologists or functional medicine practitioners
- ✓Researchers exploring the nootropic landscape for academic or clinical purposes
Exclusions
- ✕Not appropriate as a self-directed nootropic stack
- ✕Not intended for individuals with untreated psychiatric conditions
- ✕Not a replacement for evidence-based cognitive therapies
Based on cognitive testing, what does my current baseline look like?
Are there evidence-based cognitive interventions I should prioritize first?
What specialist oversight would be needed for any research compound?
How do these compounds interact with my existing medications?
What monitoring would you implement?
Print or copy these questions using the "Copy Summary" button to bring to your appointment.
Legal & Compliance Notice
Many cognitive research compounds are unscheduled in some countries but controlled in others. Legal status is highly jurisdiction-specific. Consult a licensed clinician.
The legal and regulatory status of research compounds varies by country and jurisdiction. It is the user's responsibility to understand applicable local laws before engaging with any compound.
This application does not provide personalized dosing recommendations. Users who require medical guidance should consult a qualified clinician.
Last reviewed: 2025-01-15 · Status: reviewed
Talk to a Licensed Clinician
The information in this protocol is for educational reference only. Before considering any compound, schedule a consultation with a qualified healthcare professional who can review your personal health history, order appropriate labs, and provide personalized guidance.